EP Patent

EP2365812A4 — Pharmaceutical formulations for iontophoretic delivery of a corticosteroid

Assigned to Nitric BioTherapeutics Inc · Expires 2012-05-16 · 14y expired

What this patent protects

Patent listed against naftifine-hydrochloride.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2365812A4
Jurisdiction: EP
Classification: —
Expires: 2012-05-16
Drug substance claim: No
Drug product claim: No
Assignee: Nitric BioTherapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.